Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROSEMARIE E WALCH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1366803454
CMS profile
4221887
Location
OWOSSO, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$176,607.95

302 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 7; records 51–100 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROSEMARIE E WALCH

NPI 1366803454 · CMS profile ID 4221887

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

OWOSSO, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 7; records 51–100 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366803454?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROSEMARIE E WALCH, NPI 1366803454, CMS profile ID 4221887. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366803454?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ROSEMARIE E WALCH, NPI 1366803454, CMS profile ID 4221887. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366803454?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ROSEMARIE E WALCH, NPI 1366803454, CMS profile ID 4221887, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 7; records 51–100 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1366803454?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

302 matching records · $176,607.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 302 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 302.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $513.8910/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015877125 CMS
Alexion Pharmaceuticals, Inc. $523.4510/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061178349 CMS
Alexion Pharmaceuticals, Inc. $34.3510/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061178847 CMS
Alexion Pharmaceuticals, Inc. $186.6710/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061180621 CMS
Alexion Pharmaceuticals, Inc. $64.2110/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061180625 CMS
Alexion Pharmaceuticals, Inc. $95.5210/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061180641 CMS
Alexion Pharmaceuticals, Inc. $302.2410/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061181129 CMS
Alexion Pharmaceuticals, Inc. $77.4410/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061182137 CMS
Alexion Pharmaceuticals, Inc. $86.3510/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061182143 CMS
Alexion Pharmaceuticals, Inc. $178.9010/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061182237 CMS
Alexion Pharmaceuticals, Inc. $8,850.0010/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061182711 CMS
Alexion Pharmaceuticals, Inc. $133.1410/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061179701 CMS
AbbVie Inc. $10.0610/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473231 CMS
EMD Serono, Inc. $323.2910/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032477267 CMS
Biogen, Inc. $9.5110/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012121925 CMS
AbbVie Inc. $0.3110/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473217 CMS
AbbVie Inc. $8.0910/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473225 CMS
Celgene Corporation $3.1210/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015876859 CMS
Merz Pharmaceuticals, LLC $25.5010/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048311924 CMS
Novartis Pharmaceuticals Corporation $5.9310/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993326745 CMS
Novartis Pharmaceuticals Corporation $0.8610/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993326747 CMS
EMD Serono, Inc. $6.8410/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032557509 CMS
Alexion Pharmaceuticals, Inc. $1,770.0010/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017025001 CMS
AbbVie Inc. $4.2810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473207 CMS
AbbVie Inc. $7.0110/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473213 CMS
AbbVie Inc. $29.7809/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473199 CMS
Alexion Pharmaceuticals, Inc. $4,720.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017071413 CMS
Horizon Therapeutics plc $200.0009/28/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088047 CMS
EMD Serono, Inc. $96.9709/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032464621 CMS
EMD Serono, Inc. $148.3509/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032477765 CMS
EMD Serono, Inc. $647.1209/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032477789 CMS
EMD Serono, Inc. $449.8209/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032477805 CMS
AbbVie Inc. $8.6309/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999473193 CMS
Novartis Pharmaceuticals Corporation $4.4609/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993326733 CMS
Novartis Pharmaceuticals Corporation $4.4609/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993326741 CMS
Celgene Corporation $16.6009/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015876831 CMS
Horizon Therapeutics plc $825.0009/20/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088045 CMS
Alexion Pharmaceuticals, Inc. $2,950.0009/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016977845 CMS
GENZYME CORPORATION $21.4109/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050262253 CMS
Biogen, Inc. $174.0009/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012281415 CMS
Biogen, Inc. $11.4309/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012162339 CMS
Horizon Therapeutics plc $36.9109/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088027 CMS
Horizon Therapeutics plc $4,400.0009/14/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088029 CMS
Horizon Therapeutics plc $951.9609/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088031 CMS
Horizon Therapeutics plc $223.2009/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088033 CMS
Horizon Therapeutics plc $2,640.0009/14/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088035 CMS
Horizon Therapeutics plc $2,112.0009/14/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088037 CMS
Horizon Therapeutics plc $1,584.9309/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088039 CMS
Horizon Therapeutics plc $19.1009/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088041 CMS
Horizon Therapeutics plc $98.4009/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987088043 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $700.73 11
PY2020 $390.11 7
PY2021 $10,058.00 78
PY2022 $75,045.38 315
PY2023 $176,607.95 302
PY2024 $134,178.64 174
PY2025 $166,321.57 222

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,493.40 1
PY2025 Principal investigator $92,057.28 19
PY2024 Principal investigator $85,983.00 23
PY2023 Recipient $2,028.52 1
PY2023 Principal investigator $16,100.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $201.00 12/29/2025 Non-covered Recipient Entity
MEMORIAL HEALTH CARE
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of remibrutinib in patients with secondary progressive multiple sclerosis No dispute reported 06/30/2026 1190314179
Principal investigator 1 Genentech, Inc. $505.00 12/23/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666594
Principal investigator 1 Genentech, Inc. $15,314.00 12/04/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666591
Principal investigator 1 Genentech, Inc. $505.00 11/05/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666587
Principal investigator 1 Genentech, Inc. $4,700.00 10/01/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666579
Principal investigator 1 Genentech, Inc. $169.00 09/05/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666584
Principal investigator 1 Genentech, Inc. $515.00 09/04/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666576
Principal investigator 1 Genentech, Inc. $7,002.00 08/04/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666572
Principal investigator 1 Genentech, Inc. $505.00 07/07/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666568
Principal investigator 1 Genentech, Inc. $500.00 07/01/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666534
Principal investigator 1 Genentech, Inc. $196.00 05/06/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666565
Principal investigator 1 Genentech, Inc. $2,293.00 05/05/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666561
Principal investigator 1 Genentech, Inc. $5.00 04/25/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666552
Principal investigator 1 Genentech, Inc. $1,000.00 04/23/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666558
Principal investigator 1 Genentech, Inc. $505.00 04/21/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666543
Recipient F. Hoffmann-La Roche AG $2,493.40 03/31/2025 Covered Recipient Physician Switch From Eculizumab to Satralizumab in Aquaporin 4 Immunoglobulin G–Seropositive Neuromyelitis Optica Spectrum Disorder: A Case Series Report No dispute reported 06/30/2026 1211538676
Principal investigator 1 Genentech, Inc. $3,437.00 03/14/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666548
Principal investigator 1 Genentech, Inc. $38,042.00 02/05/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666538
Principal investigator 1 Genentech, Inc. $15,314.00 02/04/2025 Non-covered Recipient Entity
THE MEMORIAL HOSPITAL MEMORIAL HEALTHCARE
Satralizumab in MOG AD No dispute reported 06/30/2026 1211666540
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,349.28 01/31/2025 Non-covered Recipient Entity
MEMORIAL HEALTH CARE
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light No dispute reported 06/30/2026 1190314181